CrossRef
Works that cite this article, indexed by Crossref.
Higher adjuvant radioactive iodine therapy dosage helps intermediate-risk papillary thyroid carcinoma patients achieve better therapeutic effect
Frontiers in Endocrinology 14 (2024)
Xue Li; Hongyuan Zheng; Chao Ma; Yanhui Ji; Xuan Wang; Danyang Sun; Zhaowei Meng; Wei Zheng
Radioactive Iodine in Differentiated Carcinoma of Thyroid: An Overview
Current Radiopharmaceuticals 17(1) (2024)
Namit Kant Singh; Balaji Ramamourthy; Neemu Hage; Sushmitha Nagaraju; Krishna Medha Kappagantu
Recombinant Human Thyrotropin Plus Radioactive Iodine Among Patients With Thyroid Cancer
JAMA Network Open 7(11) (2024)
Hui Tan; Yushen Gu; Yan Xiu; Xingmin Han; Qiang Wen; Zhongwei Lv; Wei Fan; Sijin Li; Jian Tan; Feng Wang; Wei Fu; Yifan Zhang; Jun Xin; Wei Ouyang; Xuemei Wang; Bin Liu; Yue Chen; Xuegong Liu; Yi Mo; Quanyong Luo; Jing Wang; Meng Li; Yan Di; Tao Xu; Hongcheng Shi
Real-world Data on Intermediate-risk Differentiated Thyroid Cancer Biochemical Response to 3700 or 5550 MBq of [131I]Sodium Iodide
Current Radiopharmaceuticals 18(4) (2025)
Daniel M. Machado; Daniel A. Bulzico; Lidia F. Fontes; Rossana C. R. de Mello; Simone Basso Locatelli; Priscilla B. Pujatti
AI leveraging solution for thyroid disease: advances and rationale
Network Modeling Analysis in Health Informatics and Bioinformatics 14(1) (2025)
Shanu Verma; Rashmi Popli; Harish Kumar; Brijesh Kumar Chaurasia